Market Closed -
Nasdaq Stockholm
12:00:00 2024-07-10 pm EDT
5-day change
1st Jan Change
10.05
SEK
-1.95%
-0.50%
-10.43%
Presenter SpeechJesper Söderqvist (Executives)Good morning, and welcome, and thank you for joi...
Boule Diagnostics AB Appoints Rikke Rytter as Director
May. 08
CI
Transcript : Boule Diagnostics AB, Q1 2024 Earnings Call, May 07, 2024
May. 07
Boule Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024
May. 07
CI
Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024
Feb. 06
Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024
Feb. 06
Boule Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Feb. 06
CI
Boule Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023
Feb. 06
CI
Transcript : Boule Diagnostics AB, Q3 2023 Earnings Call, Nov 09, 2023
Nov. 09
Boule Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 09
CI
Boule Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-07-24
CI
Transcript : Boule Diagnostics AB, Q1 2023 Earnings Call, May 03, 2023
23-05-03
Boule Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-02
CI
Transcript : Boule Diagnostics AB, 2022 Earnings Call, Feb 02, 2023
23-02-02
Boule Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
23-02-02
CI
Transcript : Boule Diagnostics AB, Q3 2022 Earnings Call, Nov 10, 2022
22-11-10
Boule Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-10
CI
Boule Diagnostics AB announced that it has received funding from Keel Capital Ab
22-09-06
CI
Transcript : Boule Diagnostics AB, H1 2022 Earnings Call, Jul 18, 2022
22-07-18
Boule Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
22-07-18
CI
Transcript : Boule Diagnostics AB, Q1 2022 Earnings Call, May 04, 2022
22-05-04
Boule Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-04
CI
Transcript : Boule Diagnostics AB, Q4 2021 Earnings Call, Feb 03, 2022
22-02-03
Boule Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
22-02-03
CI
Boule Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2021
22-02-03
CI
Transcript : Boule Diagnostics AB, Nine Months 2021 Earnings Call, Nov 10, 2021
21-11-10
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Companyâs product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Companyâs primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
More about the company
Last Close Price
10.25
SEK
Average target price
10.9
SEK
Spread / Average Target
+6.34%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1